Companies · Other Health Care
ARLINGTON · Other Health Care
Diligence memoA one-page analyst read on NM-ASWC Holdings, LLC — recommendation, valuation, rhythm, risks.→NM-ASWC Holdings, LLC looks over-valued against its niche peers and is at-risk on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
NM-ASWC Holdings, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
NM-ASWC Holdings, LLC is one of 5376 Other Health Care companies tracked from ARLINGTON. By capital raised it ranks among the largest (ahead of 90% of sector peers), and among the largest by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 25%.
Round size and date are reported; the stage label is inferred from round size (latest is Series B — a $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 90% of sector peers (real $). Modeled value above 90% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #21 of 91.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Code Biotherapeutics, Inc. | Series B | $47.5M | $465.5M | 3.06× |
| Candesant Biomedical, Inc. | Series B | $44.5M | $455.0M | 2.99× |
| Artis Holdings, LLC | Series B | $40.0M | $383.2M | 2.52× |
| GIO Blood Ltd | Series B | $27.3M | $375.2M | 2.47× |
| Clarapath, Inc. | Series B | $40.2M | $348.1M | 2.29× |
| Diality Inc | Series B | $42.9M | $337.4M | 2.22× |
| VA Pro 7 SNF Operations Holdings LLC | Series B | $32.0M | $333.0M | 2.19× |
| VivoSense, Inc. | Series B | $27.0M | $332.3M | 2.19× |
| Tidal Wave GPO, LLC | Series B | $34.8M | $324.3M | 2.13× |
| Peachy Corp. | Series B | $25.1M | $309.6M | 2.04× |
| Smile Source Holdings, L.P. | Series B | $32.2M | $308.7M | 2.03× |
| ASC San Rafael LLC | Series B | $28.3M | $294.9M | 1.94× |
| NM-ASWC Holdings, LLC this company | Series B | $37.0M | $255.4M | 1.68× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series B | $15.8M | 2021-12-29 | $87.5M | $221.0M | 90% |
| Series B | $21.2M | 2022-07-01 | $117.9M | $255.4M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Bijan Salehizadeh | — | 4 other | 2021-12 |
| Bennett Mears | — | — | 2021-12 |
| Lane Bowen | — | — | 2021-12 |
| Robert Marriott | — | — | 2021-12 |
| Ryan Ross | — | — | 2021-12 |
| Scott Patterson | — | — | 2022-07 |
| Tom Dixon | — | — | 2021-12 |
| Wayne Geoff | — | — | 2021-12 |
| Wayne Geoffrey | — | — | 2022-07 |
NM-ASWC Holdings, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| NoHo APC Inc. | Other Health Care | Series B | $37.0M | $265.5M | same sector · same stage |
| Nuelle, Inc. | Other Health Care | Series B | $36.6M | $156.2M | same sector · same stage |
| Imagine Pediatrics Holdings LLC | Other Health Care | Series B | $37.6M | $201.0M | same sector · same stage |
| BrainScope Company, Inc. | Other Health Care | Series B | $37.8M | $363.0M | same sector · same stage |
| Theator Inc. | Other Health Care | Series B | $38.2M | $291.7M | same sector · same stage |
| Getlabs, Inc. | Other Health Care | Series B | $35.7M | $161.7M | same sector · same stage |
| TherOx, Inc. | Other Health Care | Series B | $38.4M | $332.3M | same sector · same stage |
| Urotronic, Inc. | Other Health Care | Series B | $38.5M | $253.7M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| ASC San Rafael LLC | Other Health Care | Series B | $294.9M | 87% |
| Gbo Nnhs Asc Jv, Llc | Other Health Care | Pre-Seed | $5.4M | 85% |
| Greater New Haven ASC, LLC | Other Health Care | Pre-Seed | $590K | 85% |
| Pacific ASC, LLC | Other Health Care | Pre-Seed | $4.3M | 84% |
| Navierre Holdings, LLC | Other Health Care | Seed | $923K | 84% |
| ENTPSA ASC HoldCo, LLC | Other Health Care | Pre-Seed | $3.9M | 84% |
| Bloomfield ASC, LLC | Other Health Care | Seed | $6.9M | 83% |
| NorCal Holding Company, Inc. | Other Health Care | Series A | $100.9M | 83% |
See where NM-ASWC Holdings, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at NM-ASWC Holdings, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.